COMMUNIQUÉS West-GlobeNewswire

GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
30/07/2026
Combined sample-to-report solution pairs PacBio HiFi WGS with GenomOncology Pathology Workbench to support clinical labs in delivering configurable, reimbursement-aligned genomic reports across tumor types CLEVELAND, [...]
CooperCompanies Announces Release Date for Third Quarter 2026
30/07/2026
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9 [...]
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
30/07/2026
PARIS, 30 juill. 2026 (GLOBE NEWSWIRE) -- Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers Paris, France, le 30 juillet 2026 Place de cotation [...]
Voting Rights and Shares Capital of the Company
30/07/2026
PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés [...]
STERIS Raises Dividend to $0.69 per share
30/07/2026
DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $ [...]
Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026
30/07/2026
NEW YORK, 30 juill. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des [...]
Cellectis to Report Second Quarter Financial Results on August 6, 2026
30/07/2026
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
30/07/2026
Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT FocalTherics ™ to Announce Second Quarter 2026 Financial Results on August 13, 2026 Company to host conference call and webcast on [...]
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
30/07/2026
No Stockholder Action Required at This Time REDWOOD CITY, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that [...]
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
30/07/2026
Châtillon, France, 30 juillet 2026 DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (la « [...]
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
30/07/2026
Châtillon, France, July 30, 2026 DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts
30/07/2026
Company Introduced SodaSlim Capsules a natural dietary supplement created to support healthy metabolism and weight management as part of a balanced lifestyle. Formulated with carefully selected ingredients and essential [...]
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
31/07/2026
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026)
30/07/2026
Ipsen S.A. publie son Rapport financier semestriel 2026 (semestre clos le 30 juin 2026) Pièce jointe 2026 Rapport semestriel_Ipsen S.A.
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026)
30/07/2026
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30 June 2026) Attachment 2026 Half-year Financial Report_Ipsen S.A.
HAIR LOSS AWARENESS MONTH 2026: The Future of Hair Restoration Has Arrived
30/07/2026
Dr. Alan J. Bauman, board-certified Hair Restoration Physician and founder of Bauman Medical, at the practice's Boca Raton, FL Hair Hospital. Bauman Medical Highlights the New Era of AI Diagnostics, Regenerative [...]
Siemens Healthineers Appoints João Seabra President and Head of the Americas
30/07/2026
Erlangen, Germany, July 30, 2026 (GLOBE NEWSWIRE) -- João Seabra, head of Siemens Healthineers Enterprise Services, is appointed President and Head of the Americas for Siemens Healthineers, effective Oct. 1, 2026, [...]
SPINEWAY : Résultats semestriels 2026
30/07/2026
Ecully, le 30 juillet 2026 –19h Résultats semestriels 2026 Poursuite de la croissance Stabilité des résultats Solides relais de croissance embarqués Émission d’obligations simples pour financer le développement En [...]
Spineway : H1 2026 results
30/07/2026
H1 2026 results Continued growth Stable results Strong embedded growth drivers Issuance of straight bonds to finance future growth In thousands of euros Consolidated financial statements – Unaudited H1 2026 H1 2025 [...]

Pages